3-Chloro-1H-pyrazol-4-amine hydrochloride, 95.0%, 5g

2-Bromo-4-(pyrrolidin-1-yl)pyridine, 97.0%, 100mg

N,N-Dimethylpropionamide>98.0%(GC)500mL

5-(chloromethyl)-3-(2-methylphenyl)-1,2,4-oxadiazole, 95.0%, 5g

1-Ethyl-3-methyl-imidazolium thiocyanate, min. 98%, 100 g, glass packaging

(S)-tert-Butyl 2-amino-2-cyclohexylacetate, 98%, 25g

Bicyclo[2.2.2]octan-2-one, 95.0%, 10g

N-Boc-D-glutamic acid 1-methyl ester, 95.0%, 5g

(S)-Ethyl 6-(5-bromofuran-2-yl)-7,9-dimethyl-8,10-dioxo-11-phenyl-7,8,9,10-tetrahydro-6H-benzo[b]pyrimido[4',5':3,4]pyrrolo[1,2-d][1,4]oxazine-2-carboxylate, 98%, 1g

5-Azaspiro[2.5]octane-6,8-dione, 97%, 250mg

tert-butyl 2-(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)acetate, 95%, 500mg

7-Bromo-1H-indazole-3-carbaldehyde, 95.0%, 100mg

N-(3-Acetyl-4-hydroxyphenyl)acetamide, 97.0%, 5g